Major banks rating丨UBS Group: Raised WUXI APPTEC's Target Price to HKD 82.5, first-quarter performance exceeded expectations.
On April 29, Glonghui reported that UBS Group issued a research report indicating that WUXI APPTEC's performance in the first quarter of this year exceeded expectations. The company maintains its guidance for the year, with Business revenue forecast to grow by 10% to 15% year-on-year, reaching 41.5 billion to 43 billion yuan. At the same time, the company keeps its capital expenditure target at 7 billion to 8 billion yuan and free cash flow at 4 billion to 5 billion yuan. The bank has slightly adjusted its model based on WUXI APPTEC's first-quarter performance, predicting earnings per share of 4.12 yuan for this year, maintaining the earnings per share forecast of 4.71 yuan for next year, and slightly raising the earnings per share forecast for 2027 from 5.37 yuan to 5.38 yuan. The bank has set a target for WUXI APPTEC.
WUXI APPTEC: Q1 net profit significantly increased, maintaining double-digit growth guidance for the year | Interpretations
① WUXI APPTEC's Q1 net income attributable to the parent company grew 89.1% year-on-year, mainly due to revenue growth, improved overall profitability, and the sale of WUXI XDC stocks; ② WUXI APPTEC still believes it can achieve its annual double-digit growth target.
WUXI APPTEC: (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2024,THE 2025 FIRST A SHARE CLASS MEETING ANDTHE 2025 FIRST H SHARE CLASS MEETING;(2) PAYMENT OF FINAL DIVIDEND AND SPECIAL DIVIDEND;AND(3) AMENDMENTS TO ARTICLES OF ASSOCIATION
WuXi AppTec Reports Q1 Results
WUXI APPTEC (603259): Performance growth exceeds market expectations, with the TIDES Business contributing to core performance flexibility.
The company released its first quarter report for 2025: in Q1 2025, it achieved revenue of 9.655 billion yuan, a year-on-year increase of 20.96%, and realized a net income attributable to the parent company of 3.672 billion yuan, a year-on-year increase of 89.06%, and achieved deductive net profit.
WUXI APPTEC (02359) invested 20.0063 million yuan to repurchase 0.3294 million A-shares on April 29.
WUXI APPTEC (02359) announced that the company will invest 20.0063 million yuan on April 29, 2025...
Express News | According to information from the Hong Kong Stock Exchange, JPMorgan's long position ratio in WUXI APPTEC (2359.HK) Listed in Hong Kong decreased from 7.33% to 6.28% on April 24.
WUXI APPTEC (02359.HK) received an increase in shareholding of 4.5509 million shares Listed in Hong Kong, valued at approximately 0.264 billion Hong Kong dollars.
On April 29, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 29, FMR LLC increased its Shareholding by acquiring 4.5509 million shares of WUXI APPTEC (02359.HK) at an average price of HKD 57.9164 per share on April 24, amounting to approximately HKD 0.264 billion. After the increase, FMR LLC's latest shareholding is 44.379 million shares, with the proportion of good shares rising from 10.29% to 11.47%. Image source: Stock ownership disclosure from the Stock Exchange. What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more) must disclose their holdings.
WUXI APPTEC CO LTD UNSPON ADS EACH REP 1 ORD SHS (WUXAY.US) will release its Earnings Reports on April 28.
$WUXI APPTEC CO LTD UNSPON ADS EACH REP 1 ORD SHS(WUXAY.US)$ will release its Earnings Reports on April 28, investors are encouraged to pay attention. How were the previous performances? $WUXI APPTEC CO LTD UNSPON ADS EACH REP 1 ORD SHS(WUXAY.US)$ had a revenue of 11.539 billion yuan, Net income of 2.966 billion yuan, and an EPS of 1.02 yuan for Q4 2024. Revenue for Q1 2024 was 79.
Hong Kong Market Quick Review | The three major indices showed mixed results, with the Tech Index rising by 0.62%; Digital Health stocks were strong throughout the day, with ALI HEALTH increasing by over 7%; some autonomous driving Concept stocks rose, wi
Network Technology stocks had mixed results, with MEITUAN-W rising 2.88% and JD-SW increasing 1.90%; most Lithium Battery stocks fell, with LEOCH INT'L rising 7.76% and Tianqi Lithium Corporation increasing 2.89%; Biotechnology stocks performed well, with REMEGEN dropping 10.75% and SKB BIO-B rising 9.79%.
Morgan Stanley: WUXI APPTEC's first quarter performance exceeds expectations, fundamentals remain strong, rating "Shareholding".
Morgan Stanley released a Research Report stating that WUXI APPTEC (02359) recorded revenue and adjusted net profit under non-GAAP accounting of RMB 9.65 billion and RMB 2.68 billion respectively in the first quarter, exceeding the bank's expectations. The main drivers were the USA and Europe markets, with revenue increasing year-on-year by 28% and 26% respectively, contributing nearly 80% of the income. The bank set a Target Price of HKD 85 for its Listed in Hong Kong with a rating of 'Shareholding'. Additionally, the company's backlog of Orders for ongoing Business expanded by 47% year-on-year to RMB 52.33 billion, which, based on the first quarter's pace, is equivalent to about 5 to 6 quarters. The bank also mentioned that as a contractor in the mainland.
WUXI APPTEC(2359.HK):1Q25 RESULTS BEAT DRIVEN BY STRONG CORE GROWTH
China's WuXi AppTec Rallies as Strong Q1 Earnings Indicate Minimal Tariff Impact
WuXi AppTec Co., (WUXIF) Ltd. Q1 2025 Earnings Call Transcript Summary
Nomura: Maintain WUXI APPTEC (02359) "Buy" rating, Target Price 84.59 HKD.
In the first quarter of 2025, WUXI APPTEC's revenue and profit growth both returned to double-digit levels; the Order backlog increased by 47% year-on-year.
Citibank's report on 'The Big Deal': WUXI APPTEC (02359.HK) first quarter results exceeded expectations, TIDES performance was outstanding.
Citi published a report indicating that WUXI APPTEC (02359.HK) achieved revenue of 9.7 billion yuan in the first quarter of this year, an annual growth of 21%, with the continuous operations business growing 23% year-on-year; net profit was 3.7 billion yuan, an annual increase of 89%, growing 14.5% after excluding one-time items. The performance is strong, with revenue and net profit exceeding the bank's estimates by 4% and 10% respectively. The gross margin increased from 38.1% in the first quarter of last year to 42.3% in the first quarter of this year. This further benefitted from a decrease of 290 basis points in management expense ratio, with operating profit margin expanding from 24% in the first quarter of last year to 31.2%.
S&P Global Market Intelligence has listed the top ten shorted Hong Kong stocks recently.
S&P Global Market Intelligence has listed the ten most shorted stocks in Hong Kong as of last Friday (25th). The data is calculated based on the securities financing dataset from S&P Global Market Intelligence. The indicator for calculating short sales (short ratio) is the percentage of borrowed shares relative to the total issued shares.
Hong Kong stock market midday review | All three major indices rose, with the tech index up 0.81%; new tea beverage and Digital Health stocks performed well, with Nayuki rising over 9%, Mixue Group up nearly 6%, and ALI HEALTH up over 6%.
Network Technology stocks showed mixed results, with MEITUAN-W rising 3.82% and JD-SW increasing by 2.77%; Biotechnology stocks performed impressively, with REMEGEN falling 8.21% and WUXI APPTEC rising 6.01%; Dining stocks generally increased, with Nayuki's Tea rising 9.18% and DPC DASH falling 2.28%.
According to JPMorgan, WUXI APPTEC (02359.HK) achieved first-quarter results that exceeded expectations and is likely to reach the annual guidance.
JPMorgan's research report indicates that WUXI APPTEC (02359.HK) had a year-on-year revenue increase of 21% in the first quarter, surpassing expectations, mainly due to strong growth in the TIDES Business. The adjusted net profit under non-GAAP increased by 40% year-on-year to 2.7 billion yuan, reflecting the company's effective cost management. The company maintains its guidance for 2025, and it is believed that despite the instability brought by US tariffs, it is highly likely to achieve it based on the strong performance in the first quarter. The report also mentioned that the company's testing business (WuXi Testing) continues to face challenges, with a year-on-year decline of 5% in the first quarter's performance, adjusted under non-GAAP.
According to Morgan Stanley, WUXI APPTEC (02359.HK) surpassed expectations in its first quarter performance and remains strong in fundamentals.
Morgan Stanley published a research report stating that WUXI APPTEC (02359.HK) recorded first-quarter revenue and adjusted net profit under non-GAAP standards of 9.65 billion yuan (RMB) and 2.68 billion yuan, respectively, surpassing market expectations. The primary drivers were the USA and Europe markets, with year-on-year revenue growth of 28% and 26%, contributing nearly 80% to total revenue. Additionally, the company's backlog of Orders continued to expand by 47% year-on-year to 52.33 billion yuan, which, at the pace of the first quarter, corresponds to approximately 5 to 6 quarters. The report also mentioned that as a contract development and manufacturing organization (CDMO) in mainland China, WUXI APPTEC...